291 related articles for article (PubMed ID: 32362897)
1. Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility Antigens.
Fuchs KJ; Honders MW; van der Meijden ED; Adriaans AE; van der Lee DI; Pont MJ; Monajemi R; Kielbasa SM; 't Hoen PAC; van Bergen CAM; Falkenburg JHF; Griffioen M
Front Immunol; 2020; 11():659. PubMed ID: 32362897
[TBL] [Abstract][Full Text] [Related]
2. Identification of 4 novel HLA-B*40:01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivity.
Griffioen M; Honders MW; van der Meijden ED; van Luxemburg-Heijs SA; Lurvink EG; Kester MG; van Bergen CA; Falkenburg JH
Haematologica; 2012 Aug; 97(8):1196-204. PubMed ID: 22419570
[TBL] [Abstract][Full Text] [Related]
3. HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study.
van Balen P; Jedema I; van Loenen MM; de Boer R; van Egmond HM; Hagedoorn RS; Hoogstaten C; Veld SAJ; Hageman L; van Liempt PAG; Zwaginga JJ; Meij P; Veelken H; Falkenburg JHF; Heemskerk MHM
Front Immunol; 2020; 11():1804. PubMed ID: 32973756
[TBL] [Abstract][Full Text] [Related]
4. Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity.
Stumpf AN; van der Meijden ED; van Bergen CA; Willemze R; Falkenburg JH; Griffioen M
Blood; 2009 Oct; 114(17):3684-92. PubMed ID: 19706888
[TBL] [Abstract][Full Text] [Related]
5. Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine Endopeptidase.
Kremer AN; Bausenwein J; Lurvink E; Kremer AE; Rutten CE; van Bergen CAM; Kretschmann S; van der Meijden E; Honders MW; Mazzeo D; Watts C; Mackensen A; Falkenburg JHF; Griffioen M
Front Immunol; 2020; 11():381. PubMed ID: 32218783
[TBL] [Abstract][Full Text] [Related]
6. Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1.
Oostvogels R; Minnema MC; van Elk M; Spaapen RM; te Raa GD; Giovannone B; Buijs A; van Baarle D; Kater AP; Griffioen M; Spierings E; Lokhorst HM; Mutis T
Leukemia; 2013 Mar; 27(3):642-9. PubMed ID: 23079962
[TBL] [Abstract][Full Text] [Related]
7. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
[TBL] [Abstract][Full Text] [Related]
8. Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes.
Ofran Y; Kim HT; Brusic V; Blake L; Mandrell M; Wu CJ; Sarantopoulos S; Bellucci R; Keskin DB; Soiffer RJ; Antin JH; Ritz J
Clin Cancer Res; 2010 Mar; 16(5):1642-51. PubMed ID: 20160060
[TBL] [Abstract][Full Text] [Related]
9. CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II.
van Balen P; van Bergen CAM; van Luxemburg-Heijs SAP; de Klerk W; van Egmond EHM; Veld SAJ; Halkes CJM; Zwaginga JJ; Griffioen M; Jedema I; Falkenburg JHF
Front Immunol; 2018; 9():3016. PubMed ID: 30619360
[TBL] [Abstract][Full Text] [Related]
10. Degree of predicted minor histocompatibility antigen mismatch correlates with poorer clinical outcomes in nonmyeloablative allogeneic hematopoietic cell transplantation.
Larsen ME; Kornblit B; Larsen MV; Masmas TN; Nielsen M; Thiim M; Garred P; Stryhn A; Lund O; Buus S; Vindelov L
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1370-81. PubMed ID: 20353833
[TBL] [Abstract][Full Text] [Related]
11. A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A*2902 and -B*4403.
Terakura S; Murata M; Warren EH; Sette A; Sidney J; Naoe T; Riddell SR
Transplantation; 2007 May; 83(9):1242-8. PubMed ID: 17496542
[TBL] [Abstract][Full Text] [Related]
12. Minor histocompatibility antigens: past, present, and future.
Spierings E
Tissue Antigens; 2014 Oct; 84(4):374-60. PubMed ID: 25262921
[TBL] [Abstract][Full Text] [Related]
13. Minor histocompatibility antigens as targets of graft-versus-leukemia reactions.
Falkenburg JH; Marijt WA; Heemskerk MH; Willemze R
Curr Opin Hematol; 2002 Nov; 9(6):497-502. PubMed ID: 12394171
[TBL] [Abstract][Full Text] [Related]
14. Rapid Multiplex Genotyping of 20 HLA-A
Romaniuk DS; Postovskaya AM; Khmelevskaya AA; Malko DB; Efimov GA
Front Immunol; 2019; 10():1226. PubMed ID: 31275297
[TBL] [Abstract][Full Text] [Related]
15. Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data.
Armistead PM; Liang S; Li H; Lu S; Van Bergen CA; Alatrash G; St John L; Hunsucker SA; Sarantopoulos S; Falkenburg JH; Molldrem JJ
PLoS One; 2011; 6(8):e23217. PubMed ID: 21858034
[TBL] [Abstract][Full Text] [Related]
16. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
[TBL] [Abstract][Full Text] [Related]
17. Collateral damage of nonhematopoietic tissue by hematopoiesis-specific T cells results in graft-versus-host disease during an ongoing profound graft-versus-leukemia reaction.
van der Zouwen B; Kruisselbrink AB; Frederik Falkenburg JH; Jedema I
Biol Blood Marrow Transplant; 2014 Jun; 20(6):760-9. PubMed ID: 24607556
[TBL] [Abstract][Full Text] [Related]
18. Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMT.
Olsen KS; Jadi O; Dexheimer S; Bortone DS; Vensko SP; Bennett S; Tang H; Diiorio M; Saran T; Dingfelder D; Zhu Q; Wang Y; Haiman CA; Pooler L; Sheng X; Webb A; Pasquini MC; McCarthy PL; Spellman SR; Weimer E; Hahn T; Sucheston-Campbell L; Armistead PM; Vincent BG
Blood Adv; 2023 May; 7(9):1635-1649. PubMed ID: 36477467
[TBL] [Abstract][Full Text] [Related]
19. Computational Analysis of HLA-presentation of Non-synonymous Recipient Mismatches Indicates Effect on the Risk of Chronic Graft-vs.-Host Disease After Allogeneic HSCT.
Ritari J; Hyvärinen K; Koskela S; Niittyvuopio R; Nihtinen A; Salmenniemi U; Putkonen M; Volin L; Kwan T; Pastinen T; Itälä-Remes M; Partanen J
Front Immunol; 2019; 10():1625. PubMed ID: 31379830
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease.
Martin PJ; Levine DM; Storer BE; Warren EH; Zheng X; Nelson SC; Smith AG; Mortensen BK; Hansen JA
Blood; 2017 Feb; 129(6):791-798. PubMed ID: 27872059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
